메뉴 건너뛰기




Volumn 6, Issue 4, 2006, Pages 377-388

Chk1 inhibitors for novel cancer treatment

Author keywords

Adjuvant therapy; Anticancer agent; Cell cycle checkpoint; Chk1 inhibitor; DNA damage; DNA damaging agent; Kinase; Singnal transduction

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CEP 3891; CHECKPOINT KINASE 1; CHECKPOINT KINASE 1 INHIBITOR; CISPLATIN; CYTARABINE; DEBROMOHYMENIALDISINE; DNA; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; ICP 1; ISOGRANULATIMIDE; KARENITECIN; MITOMYCIN C; PACLITAXEL; PD 0166285; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; SB 218078; SCYTONEMIN; STAUROSPORINE; TEMOZOLOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 33745856631     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152006777698132     Document Type: Review
Times cited : (92)

References (128)
  • 16
  • 17


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.